Ratain MJ - Search Results

1

Body surface area as a determinant of pharmacokinetics and drug dosing.

Sawyer M, Ratain MJ. Sawyer M, et al. Among authors: ratain mj. Invest New Drugs. 2001 May;19(2):171-7. doi: 10.1023/a:1010639201787. Invest New Drugs. 2001. PMID: 11392451 Review.

2

Development of target-based antineoplastic agents.

Stadler WM, Ratain MJ. Stadler WM, et al. Among authors: ratain mj. Invest New Drugs. 2000 Feb;18(1):7-16. doi: 10.1023/a:1006371512390. Invest New Drugs. 2000. PMID: 10830137 Review.

3

Therapeutic relevance of pharmacokinetics and pharmacodynamics.

Ratain MJ. Ratain MJ. Semin Oncol. 1992 Aug;19(4 Suppl 11):8-13. Semin Oncol. 1992. PMID: 1509284 Review.

4

Phase I study of ZD9331 on short daily intravenous bolus infusion for 5 days every 3 weeks with fixed dosing recommendations.

Goh BC, Ratain MJ, Bertucci D, Smith R, Mani S, Vogelzang NJ, Schilsky RL, Hutchison M, Smith M, Averbuch S, Douglass E. Goh BC, et al. Among authors: ratain mj. J Clin Oncol. 2001 Mar 1;19(5):1476-84. doi: 10.1200/JCO.2001.19.5.1476. J Clin Oncol. 2001. PMID: 11230494 Clinical Trial.

5

Individualizing dosing of cancer chemotherapy.

Kobayashi K, Ratain MJ. Kobayashi K, et al. Among authors: ratain mj. Semin Oncol. 1993 Feb;20(1):30-42. Semin Oncol. 1993. PMID: 8475408 Review. No abstract available.

6

Pharmacologically based dosing of etoposide: a means of safely increasing dose intensity.

Ratain MJ, Mick R, Schilsky RL, Vogelzang NJ, Berezin F. Ratain MJ, et al. J Clin Oncol. 1991 Aug;9(8):1480-6. doi: 10.1200/JCO.1991.9.8.1480. J Clin Oncol. 1991. PMID: 2072147 Clinical Trial.

7

Pharmacodynamic-pharmacokinetic relationships and therapeutic drug monitoring.

Kobayashi K, Jodrell DI, Ratain MJ. Kobayashi K, et al. Among authors: ratain mj. Cancer Surv. 1993;17:51-78. Cancer Surv. 1993. PMID: 8137353 Review.

8

Phase I clinical and pharmacokinetic study of oral 9-aminocamptothecin (NSC-603071).

Mani S, Iyer L, Janisch L, Wang X, Fleming GF, Schilsky RL, Ratain MJ. Mani S, et al. Among authors: ratain mj. Cancer Chemother Pharmacol. 1998;42(1):84-7. doi: 10.1007/s002800050789. Cancer Chemother Pharmacol. 1998. PMID: 9619763 Clinical Trial.

9

Adaptive control of etoposide administration: impact of interpatient pharmacodynamic variability.

Ratain MJ, Schilsky RL, Choi KE, Guarnieri C, Grimmer D, Vogelzang NJ, Senekjian E, Liebner MA. Ratain MJ, et al. Clin Pharmacol Ther. 1989 Mar;45(3):226-33. doi: 10.1038/clpt.1989.22. Clin Pharmacol Ther. 1989. PMID: 2920497 Clinical Trial.

10

Pharmacodynamic modeling of prolonged administration of etoposide.

Minami H, Ratain MJ, Ando Y, Shimokata K. Minami H, et al. Among authors: ratain mj. Cancer Chemother Pharmacol. 1996;39(1-2):61-6. doi: 10.1007/s002800050538. Cancer Chemother Pharmacol. 1996. PMID: 8995500 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

570 results

Search Page